跳至主要内容
临床试验/NCT04330755
NCT04330755已完成4 期

The Effect of Levosimendan Versus Its Combination to Magnesium Sulphate on Spinal Cord Protection Guided by NIRS in Infants Undergoing Coarctectomy: A Randomized Controlled Study.

Dalia Saad Abd-El Kader1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年2月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Near Infrared Spectroscopy value

研究概览

简要总结

In pediatric patients ,undergoing elective surgical correction of aortic coarcatation one of our main concern is spinal cord protection .Our aim to study the protective effect of levosimendan versus its combination with magnesium sulphate .

详细描述

Effect of levosimendan and its combination with magnesium sulphate infusion as spinal cord protection using NIRS values before Aortic cross clamp and 10,20 min after cross clamp till the end of surgery .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Day 至 12 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Age group ranging from 0 to 12 months of both sexes. Aortic coarcatation eligible for correction

排除标准

  • Parents or guardian refusal. Age more than12 months. Significant left ventricular dysfunction Patient with Heart block Patient with pre-existing CNS disorder eg seizure Patient with renal or hepatic dysfunction

研究组 & 干预措施

Group C

Placebo Comparator

Control group will received saline

干预措施: Saline Solution (Drug)

Group L

Active Comparator

Levosimendan group will received levosimendan infusion

干预措施: Levosimendan (Drug)

Group M

Active Comparator

Levosimendan and Magnesium sulphate group will received both drugs

干预措施: Levosimendan (Drug)

Group M

Active Comparator

Levosimendan and Magnesium sulphate group will received both drugs

干预措施: Magnesium Sulfate (Drug)

结局指标

主要结局

Near Infrared Spectroscopy value

时间窗: Perioperative(immediately before cross clamp,10&20 min after cross clamping Aorta)

After aortic cross clamping to compare the spinal cord protective effect of levosimendan versus its combination with magnesium sulphate.

次要结局

未报告次要终点

研究者

发起方
Dalia Saad Abd-El Kader
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dalia Saad Abd-El Kader

Principle investigator

Kasr El Aini Hospital

研究点 (1)

Loading locations...

相似试验

Levosimendan Versus Combination With Magnesium... | 临床试验